v3.19.3
Note 1 - Organization and Basis of Presentation (Details Textual)
May 03, 2019
Sep. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Cash and Cash Equivalents, at Carrying Value, Ending Balance   $ 331,000 $ 1,887,000 $ 1,760,000
Retained Earnings (Accumulated Deficit), Ending Balance   (46,312,000) $ (37,279,000)  
Convertible Debt [Member]        
Notes Payable, Total   6,600,000    
Oxford Finance, LLC [Member]        
Loans Payable, Total   $ 3,000,000    
Reverse Stock Split From [Member] | Alliqua Biomedical, Inc. [Member]        
Stockholders' Equity Note, Stock Split, Conversion Ratio 6      
Alliqua Biomedical, Inc. [Member]        
Business Acquisition, Exchange Ratio 0.0359